Subcutaneous checkpoint inhibition is equivalent to systemic delivery when combined with nelitolimod delivered via pressure-enabled drug delivery for depletion of intrahepatic myeloid-derived suppressor cells and control of liver metastases
皮下注射免疫检查点抑制剂与通过压力给药方式递送的奈利托莫德联合使用,在清除肝内髓系来源抑制细胞和控制肝转移方面,其效果与全身给药相当。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-008837
Ghosh, Chandra C; Cournoyer, Lauren; Liu, Yujia; Ballarin, Alizee; Layman, Ilan B; LaPorte, Jason; Morrissey, Molly; Fraser, Kayla; Perati, Shriya; Cox, Bryan F; Yakirevich, Evgeny; Treaba, Diana O; Murtha, Timothy D; Guha, Prajna; Katz, Steven C; Davar, Diwakar